Molecular targeting with the small molecule inhibitor Aldi-6 reduced ALDH+ cells, decreased tumor burden and sensitized HNSCC cells for cisplatin treatment [188]. This evidence concerns the gene LDHA and head and neck squamous cell carcinoma.